tirzepatide surmount 5 ESC 2025: post-hoc SURMOUNT-5 data affirms tirzepatide's lead in CVD risk reduction New GLP-1 clinical trial data

Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis

GLP-1 receptor agonists, once primarily prescribed for Type 2 Diabetes, have evolved into a multi-billion-dollar therapeutic category reshaping obesity treatment, cardiovascular care, metabolic health, and potentially even neurological disorders

However, our professional recommendation

Genetics 77 , 7194 (1974)

These checkpoints provide concrete evidence of metabolic restoration and help providers refine tirzepatide dosing and timing to align with your fertility goals

Early real-world data say a gradual taper with coaching can keep weight steady for about six months